TD Cowen Maintains a Hold on Pfizer Inc. (PFE) With a $30 PT

By Noor Ul Ain Rehman | November 11, 2025, 9:55 PM

Pfizer Inc. (NYSE:PFE) is one of the best undervalued stocks to buy under $50. Pfizer Inc. (NYSE:PFE) received a rating update from TD Cowen analyst Steve Scala on November 4, who maintained a Hold rating on the stock and set a $30 price target.

Pfizer’s (PFE) Pipeline and Dividend Yield Make it a Compelling Income Stock

Pfizer Inc. (NYSE:PFE) reported its fiscal Q3 2025 results the same day, announcing that revenue for the quarter experienced a 7% year-over-year operational decline to $16.7 billion. The operational decrease was attributed to a year-over-year decline in COVID-19 product revenues, primarily because of lower infection rates affecting the demand for Paxlovid  along with a “narrower” vaccine recommendation for COVID-19 in the United States, reducing the eligible population for Comirnaty. However, strengthening commercial execution led to a 4% operational revenue growth of the non-COVID portfolio.

The company further reported that fiscal Q3 2025 diluted EPS was $0.62, and adjusted diluted EPS reached $0.87. Management reaffirmed the full-year 2025 revenue guidance in the $61.0 to $64.0 billion range, and raised and narrowed adjusted diluted EPS guidance to a range of $3.00 to $3.15 from $2.90 to $3.10 previously.

Management stated that the updated adjusted diluted EPS guidance factors in the company’s solid year-to-date performance, progress with ongoing cost improvement initiatives, continued confidence in the business, and improvement in its effective tax rate.

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets, and sells biopharmaceutical products worldwide. It advances wellness, prevention, treatment, and cures in developing and emerging markets.

While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

Mentioned In This Article

Latest News